Radiation-induced alterations in the recurrent glioblastoma microenvironment: Therapeutic implications

Kshama Gupta, Terence Burns

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Glioblastoma (GBM) is uniformly fatal with a median survival of just over 1 year, despite best available treatment including radiotherapy (RT). Impacts of prior brain RT on recurrent tumors are poorly understood, though increasing evidence suggests RT-induced changes in the brain microenvironment contribute to recurrent GBM aggressiveness. The tumor microenvironment impacts malignant cells directly and indirectly through stromal cells that support tumor growth. Changes in extracellular matrix (ECM), abnormal vasculature, hypoxia, and inflammation have been reported to promote tumor aggressiveness that could be exacerbated by prior RT. Prior radiation may have long-term impacts on microglia and brain-infiltrating monocytes, leading to lasting alterations in cytokine signaling and ECM. Tumor-promoting CNS injury responses are recapitulated in the tumor microenvironment and augmented following prior radiation, impacting cell phenotype, proliferation, and infiltration in the CNS. Since RT is vital to GBM management, but substantially alters the tumor microenvironment, we here review challenges, knowledge gaps, and therapeutic opportunities relevant to targeting pro-tumorigenic features of the GBM microenvironment. We suggest that insights from RT-induced changes in the tumor microenvironment may provide opportunities to target mechanisms, such as cellular senescence, that may promote GBM aggressiveness amplified in previously radiated microenvironment.

Original languageEnglish (US)
Article number503
JournalFrontiers in Oncology
Volume8
Issue numberNOV
DOIs
StatePublished - Jan 1 2018

Fingerprint

Glioblastoma
Tumor Microenvironment
Radiotherapy
Radiation
Extracellular Matrix
Neoplasms
Brain
Therapeutics
Cell Aging
Microglia
Stromal Cells
Monocytes
Cell Proliferation
Cytokines
Inflammation
Phenotype
Wounds and Injuries
Growth

Keywords

  • Extracellular matrix
  • Glioblastoma
  • Radiotherapy
  • Recurrence
  • Tumor microenvironment

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Radiation-induced alterations in the recurrent glioblastoma microenvironment : Therapeutic implications. / Gupta, Kshama; Burns, Terence.

In: Frontiers in Oncology, Vol. 8, No. NOV, 503, 01.01.2018.

Research output: Contribution to journalReview article

@article{bb8756e0332e478c81eb1889c609239e,
title = "Radiation-induced alterations in the recurrent glioblastoma microenvironment: Therapeutic implications",
abstract = "Glioblastoma (GBM) is uniformly fatal with a median survival of just over 1 year, despite best available treatment including radiotherapy (RT). Impacts of prior brain RT on recurrent tumors are poorly understood, though increasing evidence suggests RT-induced changes in the brain microenvironment contribute to recurrent GBM aggressiveness. The tumor microenvironment impacts malignant cells directly and indirectly through stromal cells that support tumor growth. Changes in extracellular matrix (ECM), abnormal vasculature, hypoxia, and inflammation have been reported to promote tumor aggressiveness that could be exacerbated by prior RT. Prior radiation may have long-term impacts on microglia and brain-infiltrating monocytes, leading to lasting alterations in cytokine signaling and ECM. Tumor-promoting CNS injury responses are recapitulated in the tumor microenvironment and augmented following prior radiation, impacting cell phenotype, proliferation, and infiltration in the CNS. Since RT is vital to GBM management, but substantially alters the tumor microenvironment, we here review challenges, knowledge gaps, and therapeutic opportunities relevant to targeting pro-tumorigenic features of the GBM microenvironment. We suggest that insights from RT-induced changes in the tumor microenvironment may provide opportunities to target mechanisms, such as cellular senescence, that may promote GBM aggressiveness amplified in previously radiated microenvironment.",
keywords = "Extracellular matrix, Glioblastoma, Radiotherapy, Recurrence, Tumor microenvironment",
author = "Kshama Gupta and Terence Burns",
year = "2018",
month = "1",
day = "1",
doi = "10.3389/fonc.2018.00503",
language = "English (US)",
volume = "8",
journal = "Frontiers in Oncology",
issn = "2234-943X",
publisher = "Frontiers Media S. A.",
number = "NOV",

}

TY - JOUR

T1 - Radiation-induced alterations in the recurrent glioblastoma microenvironment

T2 - Therapeutic implications

AU - Gupta, Kshama

AU - Burns, Terence

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Glioblastoma (GBM) is uniformly fatal with a median survival of just over 1 year, despite best available treatment including radiotherapy (RT). Impacts of prior brain RT on recurrent tumors are poorly understood, though increasing evidence suggests RT-induced changes in the brain microenvironment contribute to recurrent GBM aggressiveness. The tumor microenvironment impacts malignant cells directly and indirectly through stromal cells that support tumor growth. Changes in extracellular matrix (ECM), abnormal vasculature, hypoxia, and inflammation have been reported to promote tumor aggressiveness that could be exacerbated by prior RT. Prior radiation may have long-term impacts on microglia and brain-infiltrating monocytes, leading to lasting alterations in cytokine signaling and ECM. Tumor-promoting CNS injury responses are recapitulated in the tumor microenvironment and augmented following prior radiation, impacting cell phenotype, proliferation, and infiltration in the CNS. Since RT is vital to GBM management, but substantially alters the tumor microenvironment, we here review challenges, knowledge gaps, and therapeutic opportunities relevant to targeting pro-tumorigenic features of the GBM microenvironment. We suggest that insights from RT-induced changes in the tumor microenvironment may provide opportunities to target mechanisms, such as cellular senescence, that may promote GBM aggressiveness amplified in previously radiated microenvironment.

AB - Glioblastoma (GBM) is uniformly fatal with a median survival of just over 1 year, despite best available treatment including radiotherapy (RT). Impacts of prior brain RT on recurrent tumors are poorly understood, though increasing evidence suggests RT-induced changes in the brain microenvironment contribute to recurrent GBM aggressiveness. The tumor microenvironment impacts malignant cells directly and indirectly through stromal cells that support tumor growth. Changes in extracellular matrix (ECM), abnormal vasculature, hypoxia, and inflammation have been reported to promote tumor aggressiveness that could be exacerbated by prior RT. Prior radiation may have long-term impacts on microglia and brain-infiltrating monocytes, leading to lasting alterations in cytokine signaling and ECM. Tumor-promoting CNS injury responses are recapitulated in the tumor microenvironment and augmented following prior radiation, impacting cell phenotype, proliferation, and infiltration in the CNS. Since RT is vital to GBM management, but substantially alters the tumor microenvironment, we here review challenges, knowledge gaps, and therapeutic opportunities relevant to targeting pro-tumorigenic features of the GBM microenvironment. We suggest that insights from RT-induced changes in the tumor microenvironment may provide opportunities to target mechanisms, such as cellular senescence, that may promote GBM aggressiveness amplified in previously radiated microenvironment.

KW - Extracellular matrix

KW - Glioblastoma

KW - Radiotherapy

KW - Recurrence

KW - Tumor microenvironment

UR - http://www.scopus.com/inward/record.url?scp=85063258312&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063258312&partnerID=8YFLogxK

U2 - 10.3389/fonc.2018.00503

DO - 10.3389/fonc.2018.00503

M3 - Review article

AN - SCOPUS:85063258312

VL - 8

JO - Frontiers in Oncology

JF - Frontiers in Oncology

SN - 2234-943X

IS - NOV

M1 - 503

ER -